Known as pre-methylenomycin C lactone, this antibiotic is derived from a model species that’s been studied for nearly 80 ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious ‘techbio’ company positions itself for its next phase of AI ...

Discover key insights from Schrödinger’s Q3 2025 earnings: revenue growth, updated guidance, cost reductions, and long-term market opportunities.

The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...

Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...

The MARBLES team is excited to share a new breakthrough from the project! The study led by the University of Aberdeen and ...

Harvard and Northwestern researchers combine AI and physics to design unstable proteins that comprise the dark proteome.

Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in ...

Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...

Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President ...